Pipeline

Programme
Research
Pre-clinical
Phase 1
Phase 2
Partner
Internal
pre|CISION AVA6000 – FAPα activated doxorubicin
pre|CISION™ AVA3996 – FAPα activated proteasome inhibitor
AVA028 / 032 – PD-L1 Affimer® / ImmunoCytokines
AVA021 – PD-L1 Affimer® / LAG-3 Affimer®
TMAC® platform
Undisclosed targets
Undisclosed targetsResearch
Partnered
LR19128 PD-L1 XT®
LG_Chem
Undisclosed targets
Undisclosed targetsResearch
LG_Chem
AFX-001 Solid Organ Transplant
get_company_logo
AFX-001 Graft vs Host Disease
get_company_logo
AFX-002 Multiple Sclerosis
get_company_logo